2026-04-13T19:05:09Zhttps://recercat.cat/oai/requestoai:recercat.cat:10230/692322025-12-12T03:55:29Zcom_2072_6col_2072_452952
Late-onset NPM1 mutation in a MYC-amplified relapsed/refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib
Jaramillo, Sonia
Scherer, Michael
Szu-Tu, Chelsea
Beneyto Calabuig, Sergi
Müller-Tidow, Carsten
Schlenk, Richard F.
Hundemer, Michael
Velten, Lars
Pabst, Caroline
Leucèmia mieloide aguda
2025-01-22T07:24:27Z
2025-01-22T07:24:27Z
2024
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Haematologica. 2024 Nov 1;109(11):3811-5
Copyright (c) 2024 Ferrata Storti Foundation. This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/).
http://creativecommons.org/licenses/by-nc/4.0/
info:eu-repo/semantics/openAccess
Ferrata Storti Foundation